Scott Black's ABBV Position Overview
Scott Black (via Delphi Management INC /Ma/) currently holds 6,720 shares of AbbVie Inc. (ABBV) worth $1.54 M, representing 1.49% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Scott Black has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 32,425 shares. Largest reduction occurred in Q4 2015, reducing 114,057 shares.
Analysis based on 13F filings available since 2013 Q2
Scott Black's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Scott Black
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -210 | Reduce 3.03% | 6,720 | $228.42 |
| Q3 2025 | +1,323 | Add 23.60% | 6,930 | $231.60 |
| Q2 2025 | -398 | Reduce 6.63% | 5,607 | $185.66 |
| Q1 2025 | -615 | Reduce 9.29% | 6,005 | $209.49 |
| Q4 2024 | -73 | Reduce 1.09% | 6,620 | $177.64 |
| Q3 2024 | -1,225 | Reduce 15.47% | 6,693 | $197.52 |
| Q2 2024 | +12 | Add 0.15% | 7,918 | $171.51 |
| Q1 2024 | -1,351 | Reduce 14.59% | 7,906 | $182.14 |
| Q4 2023 | +1,316 | Add 16.57% | 9,257 | $121.42 |
| Q3 2023 | +16 | Add 0.20% | 7,941 | $149.10 |
| Q2 2023 | +7,926 | Add 0.00% | 7,925 | $134.76 |
| Q4 2022 | +8,160 | Add 0.00% | 8,159 | $161.66 |
| Q4 2021 | +396 | Add 3.40% | 12,054 | $135.39 |
| Q3 2021 | +126 | Add 1.09% | 11,658 | $107.91 |
| Q2 2021 | +236 | Add 2.09% | 11,532 | $112.64 |
| Q1 2021 | +11,297 | Add 0.00% | 11,296 | $108.18 |
| Q3 2019 | -408 | Reduce 2.94% | 13,453 | $75.75 |
| Q2 2019 | -20 | Reduce 0.14% | 13,861 | $72.72 |
| Q1 2019 | -4,524 | Reduce 24.58% | 13,881 | $80.61 |
| Q4 2018 | +476 | Add 2.65% | 18,405 | $92.20 |
| Q3 2018 | -592 | Reduce 3.20% | 17,929 | $94.60 |
| Q2 2018 | -3,726 | Reduce 16.75% | 18,521 | $92.22 |
| Q1 2018 | -5,498 | Reduce 19.82% | 22,247 | $94.66 |
| Q4 2017 | -5,204 | Reduce 15.79% | 27,745 | $96.70 |
| Q3 2017 | -104 | Reduce 0.31% | 32,949 | $88.86 |
| Q2 2017 | -7,814 | Reduce 19.12% | 33,053 | $72.52 |
| Q1 2017 | +3,051 | Add 8.07% | 40,867 | $65.16 |
| Q4 2016 | +1,068 | Add 2.91% | 37,816 | $62.62 |
| Q3 2016 | -3,390 | Reduce 8.45% | 36,748 | $63.08 |
| Q2 2016 | -1,821 | Reduce 4.34% | 40,138 | $61.91 |
| Q1 2016 | +1,161 | Add 2.85% | 41,959 | $57.13 |
| Q4 2015 | -114,057 | Reduce 73.65% | 40,798 | $59.24 |
| Q3 2015 | +2,945 | Add 1.94% | 154,855 | $54.41 |
| Q2 2015 | +32,425 | Add 27.14% | 151,910 | $67.19 |
| Q1 2015 | +119,485 | New Buy | 119,485 | $58.54 |
Scott Black's AbbVie Investment FAQs
Scott Black first purchased AbbVie Inc. (ABBV) in Q1 2015, acquiring 119,485 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Scott Black has held AbbVie Inc. (ABBV) for 44 quarters since Q1 2015.
Scott Black's largest addition to AbbVie Inc. (ABBV) was in Q1 2015, adding 119,485 shares worth $7 M.
According to the latest 13F filing for Q4 2025, Scott Black's firm, Delphi Management INC /Ma/, owns 6,720 shares of AbbVie Inc. (ABBV), valued at approximately $1.54 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 1.49% of Scott Black's publicly disclosed stock portfolio, making it one of their key holdings.
Scott Black's peak holding in AbbVie Inc. (ABBV) was 154,855 shares, as reported at the end of Q3 2015.